AgomAb Therapeutics private stock trade

AgomAb Therapeutics

Legal NameAgomAb Therapeutics NV
HeadquartersGhent
SectorBioTech

AgomAb Therapeutics is a biotechnology company specializing in the development of therapeutic antibodies. The company focuses on creating innovative antibody-based treatments for various diseases and medical conditions. AgomAb Therapeutics' expertise lies in antibody engineering and optimization to target specific disease pathways effectively. The company aims to improve healthcare outcomes by providing user-friendly and targeted antibody therapies that address unmet medical needs, ultimately contributing to better treatment options and patient care in the field of biomedicine.

Learn more about AgomAb Therapeutics IPO

Secondary Pricing Information

$ .star in blue circleZX Index Value | Get ZXData access
--ZX Index Value MoM Change
--ZX Index Value VS Reported Marks
pricing graph placeholder
star in blue circleTo view Pre-IPO pricing data for AgomAb Therapeutics, log in to ZXData or contact us to request access.
<

Secondary Volume Information

$ .M star in blue circleAggregate Volume | Get ZXData access
volume graph placeholder
star in blue circleTo view Pre-IPO volume data for AgomAb Therapeutics, log in to ZXData or contact us to request access.
View More

ZXData is the leading provider of real-time secondary data on private companies. ZXData has the largest dataset of closed trades with $15bn+ in volume. In addition, it incorporates $150bn+ of buy/sell prices and $45bn+ of reported marks to provide private market investors, trading desks, lenders, and companies with unprecedented market intelligence on private companies.